{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T16:41:04.563759",
  "document": "10_.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/10_.pdf",
  "total_candidates": 535,
  "total_validated": 30,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "heuristics_counters": {
    "recovered_by_stats_whitelist": 1,
    "recovered_by_country_code": 0,
    "recovered_by_hyphen": 0,
    "recovered_by_direct_search": 0,
    "recovered_by_llm_sf_only": 7,
    "blacklisted_fp_count": 5,
    "common_word_rejected": 10,
    "context_rejected": 0,
    "form_filter_rejected": 59,
    "trial_id_excluded": 0
  },
  "abbreviations": [
    {
      "short_form": "SD",
      "long_form": "standard deviation",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "The EuroQoL five-dimension three-level questionnaire (EQ-SD-3L), a well-established generic questionnaire used in rheumatology [14, 16], that measures HRQoL in five dimensions — mobility, self-care, daily activities, pain/discomfort and anxiety/depression — using three levels of severity: no problems, moderate problems and severe problems. It is generally u",
      "lexicon_source": "2025_08_umls_biological_abbreviations_v5.tsv",
      "lexicon_ids": [
        {
          "source": "UMLS:MTH",
          "id": "SD"
        }
      ]
    },
    {
      "short_form": "AAV",
      "long_form": "ANCA associated vasculi",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Abstract Objectives: To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculi-tis (AAV).",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "HADS",
      "long_form": "Hospital Anxiety and Depression Score",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "es: To explore health-related quality of life (HROoL), anxiety, depression and fatigue among persons with ANCA-associated vasculi-tis (AAV). Methods: In this cross-sectional study, patients were assessed with the EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS), the Hospital Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF).",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "ANCA",
      "long_form": "Antineutrophil cytoplasmic antibody",
      "confidence": 0.95,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "kidneys, respiratory system and ear, nose and throat. It is equally distributed between men and women, and most common in older adults [2]. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of chronic vasculitis, character-ized by inflammation predominantly in small vessels and consists of three main subtypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA) [1]. AAV is a heterogeneous disease, characterized by systemic symptoms such as fever, joint pain and manifest",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "EGPA",
      "long_form": "eosinophilic granulomatosis with polyangiitis",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "ly distributed between men and women, and most common in older adults [2]. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of chronic vasculitis, character-ized by inflammation predominantly in small vessels and consists of three main subtypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA) [1]. AAV is a heterogeneous disease, characterized by systemic symptoms such as fever, joint pain and manifestations from the eyes, nervous",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "HRQoL",
      "long_form": "health related quality of life",
      "confidence": 0.95,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "AAV is a heterogeneous disease, characterized by systemic symptoms such as fever, joint pain and manifestations from the eyes, nervous Gz0Z Both the disease itself and its treatment can cause patients to experience a multifactorial disease burden affecting several domains of health. Reduced health-related quality of life (HRQoL), fatigue and psychological distress including anxiety and depression are common among AAV patients [3-5]. Decreased HRQoL in AAV has been found to be associated",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "BMI",
      "long_form": "body mass index",
      "confidence": 0.95,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "Disease and patient characteristics Diagnosis of AAV, disease activity, disease duration, age, gender, prednisolone dose, body mass index (BMI) and level of education were collected by a physician during the study visit.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "BVAS",
      "long_form": "Birmingham Vasculitis Activity Score",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "duration, age, gender, prednisolone dose, body mass index (BMI) and level of education were collected by a physician during the study visit. Disease activity was evaluated with the Birmingham Vasculitis Activity Score (BVAS), a physician-completed questionnaire that assesses disease activity in nine organs and produces a score ranging from 0 to 63 [20]. A score of zero was considered inactive disease and a score of >1was defined as active disease.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "IQR",
      "long_form": "interquartile range",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "Gz0Z 4equiaceq g} UO esn Descriptive statistics such as frequency distribution, median, minimum, maximum, interquartile range (IQR) and percent-age were used to characterize the study cohort.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "GPA",
      "long_form": "granulomatosis with polyangiitis",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 3,
      "context_text": "BVAS: Birmingham Vasculitis Activity Score; EGPA: eosinophilic granulomatosis with polyangiitis; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "MPA",
      "long_form": "microscopic polyangiitis",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 3,
      "context_text": "BVAS: Birmingham Vasculitis Activity Score; EGPA: eosinophilic granulomatosis with polyangiitis; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "SF-36",
      "long_form": "Short Form-36",
      "confidence": 1.0,
      "field_type": "DEFINITION_PAIR",
      "page": 6,
      "context_text": "upported by the Swedish Rheumatism Association [ST-202111 to A.G.] [R-1025817 to I.G]. Stockholm County Council Regional Council (ALF) [FoUI In this study, HRQoL was measured using EQ-5D-3L, although the Short Form-36 (SF-36) questionnaire is more commonly used in vasculitis research [14, 27]. The SF-36 has",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "AAV-PRO",
      "long_form": "ANCA associated vasculitis patient reported outcomes",
      "confidence": 0.95,
      "field_type": "DEFINITION_PAIR",
      "page": 8,
      "context_text": "5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy. Epilepsy Behav EB 2022; 127:108554. 44, Robson JC, Dawson J, Doll H et al. Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis 2018;77:1157-64.",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "ALF",
      "long_form": "Stockholm County Council Regional Council",
      "confidence": 0.8,
      "field_type": "DEFINITION_PAIR",
      "page": 6,
      "context_text": "This work was supported by the Swedish Rheumatism Association [ST-202111 to A.G.] [R-1025817 to I.G]. Stockholm County Council Regional Council (ALF) [FoUI",
      "lexicon_source": "inline_definition",
      "lexicon_ids": null
    },
    {
      "short_form": "EQ-VAS",
      "long_form": "EuroQol Visual Analogue Scale",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Methods: In this cross-sectional study, patients were assessed with the EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS), the Hospital Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF).",
      "lexicon_source": "pro_scales_lexicon.json",
      "lexicon_ids": [
        {
          "source": "ClinicalTrials.gov",
          "id": "NCT02679755"
        }
      ]
    },
    {
      "short_form": "ADL",
      "long_form": "interference in activities of daily living",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "The Multidimensional Assessment of Fatigue questionnaire (MAF), originally developed to measure fatigue in rheuma-toid arthritis, and later validated for several rheumatic diseases, contains 16 items measuring four dimensions of fatigue during the previous week: severity, distress, interference in activities of daily living (ADL) and timing (in terms of frequency and change). A global fatigue index is calculated by summing the total scores from the severity and distress subscales, the average score for the degree of interference in ADL, and one timing item. The global fatigue index ranges from 1 to 50, with a higher score r",
      "lexicon_source": "inline_definition",
      "lexicon_ids": null
    },
    {
      "short_form": "HADS-A",
      "long_form": "HADS Anxiety Subscale",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 2,
      "context_text": "The distributions of EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D were expressed as median and IQR. To compare distributions of the EQ-5SD index, EQ-VAS, MAF, HADS-A and HADS-D between groups of diagnosis, disease activity, disease duration, age, and gender, the MannWhitney U test or Kruskal-Wallis H test was performed.",
      "lexicon_source": "pro_scales_lexicon.json",
      "lexicon_ids": [
        {
          "source": "ClinicalTrials.gov",
          "id": "NCT06813196"
        }
      ]
    },
    {
      "short_form": "EQ-5D-3L",
      "long_form": "European Quality of Life Health 5-item Questionnaire 3-Level",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Methods: In this cross-sectional study, patients were assessed with the EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS), the Hospital Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF).",
      "lexicon_source": "2025_08_abbreviation_general.json",
      "lexicon_ids": null
    },
    {
      "short_form": "EuroQoL",
      "long_form": "European Quality of Life questionnaire",
      "confidence": 0.8,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Methods: In this cross-sectional study, patients were assessed with the EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS), the Hospital Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF).",
      "lexicon_source": "2025_08_abbreviation_general.json",
      "lexicon_ids": null
    },
    {
      "short_form": "VAS",
      "long_form": "Visual Analogue Scale",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Methods: In this cross-sectional study, patients were assessed with the EuroQoL five-dimension three-level questionnaire (EQ-5D-3L) and visual analogue scale (EQ-VAS), the Hospital Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF).",
      "lexicon_source": "2025_08_abbreviation_general.json",
      "lexicon_ids": null
    },
    {
      "short_form": "EQ-5D",
      "long_form": "European Quality of Life Health 5-item Questionnaire",
      "confidence": 0.8,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "patients with shorter disease duration reported more anxiety, and younger persons with active disease and short disease duration reported more fatigue. In the total group, disease activity and disease duration were both associated with HROoL, anxiety, depression and fatigue. Four clusters based on EQ-5D, EQ-5D. index and HADS were identified, containing patients with various levels of HROoL and psychological distress across the disease course.",
      "lexicon_source": "2025_08_abbreviation_general.json",
      "lexicon_ids": null
    },
    {
      "short_form": "EQVAS",
      "long_form": "EuroQol Visual Analogue Scale",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 6,
      "context_text": "In line with earlier research [48, 49], we found that EQVAS was better able than the EQ-5D index to distinguish between different levels of HRQoL. In addition, EQ-VAS scores could discriminate between patients with inactive vs active disease, long and short disease duration and different age categories, whereas differences in EQ-5D index scores were only fo",
      "lexicon_source": "pro_scales_lexicon.json",
      "lexicon_ids": [
        {
          "source": "ClinicalTrials.gov",
          "id": "NCT03660137"
        }
      ]
    },
    {
      "short_form": "PRO",
      "long_form": "Patient-reported outcomes",
      "confidence": 0.9,
      "field_type": "DEFINITION_PAIR",
      "page": 6,
      "context_text": "hin rheumatology widely used generic questionnaires [14, 16-19]. Although this has the benefit of allowing comparison with other patient groups, these questionnaires lack the ability to capture the disease-specific burden of AAV. Use of disease-and treatment-specific questionnaires, such as the AAV-PRO [44], might capture the disease-specific aspects for patients living with AAV, and future studies should ideally include such instruments. Furthermore, performing qualitative studies could uncover additional knowledge and lead to improvement in AAV care [14, 45, 46]. To prevent overestimation or un",
      "lexicon_source": null,
      "lexicon_ids": null
    },
    {
      "short_form": "SC",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "64, 6233-6240 https://doi.org/10.1093/rheumatology/keaf417 Advance access publication 8 August 2025 SC British Society for e Rheumatology RHEUMATOLOGY Original Article OXFORD Clinical science Exploratio",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "MAF",
      "long_form": "Multidimensional Assessment of Fatigue questionnaire",
      "confidence": 0.85,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": " Anxiety and Depression Score (HADS) and the Multidimensional Assessment of Fatigue question-naire (MAF). Results: HROoL measured with EQ-VAS was higher in younger patients, those with inactive disease (",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "HROOL",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": " activity, disease duration, gender and age. Associations between disease activity and duration and HROOL, anxiety, depression and fatigue were present in all patients. Four clusters revealed the ongoing i",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "VASKA",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "er 18 years of age, who had been diagnosed with either GPA, MPA or EGPA and who participated in the VASKA study at Karolinska University Hospital, Sweden, between 2008 and 2022. Patients were recruited fro",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "EQ-SD-3L",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "y [21, 22]. Patient-reported outcome measures The EuroQoL five-dimension three-level questionnaire (EQ-SD-3L), a well-established generic questionnaire used in rheumatology [14, 16], that measures HRQoL in fi",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "HADS-D",
      "long_form": null,
      "confidence": 0.75,
      "field_type": "SHORT_FORM_ONLY",
      "page": 1,
      "context_text": "re used to characterize the study cohort. The distributions of EQ-5D index, EQ-VAS, MAF, HADS-A and HADS-D were expressed as median and IQR. To compare distributions of the EQ-5SD index, EQ-VAS, MAF, HADS-A",
      "lexicon_source": "orchestrator:llm_extraction",
      "lexicon_ids": null
    },
    {
      "short_form": "IBM",
      "long_form": "Inclusion body myositis",
      "confidence": 0.85,
      "field_type": "DEFINITION_PAIR",
      "page": 1,
      "context_text": "Supplementary Table $1, available at Rheumatology online). Data were analysed using version 28.0 of IBM SPSS Statistics for Windows (IBM Corp, Armonk, NY, USA). MAF scores were higher for patients with a",
      "lexicon_source": "orchestrator:llm_extraction:lexicon_fallback",
      "lexicon_ids": null
    }
  ],
  "diseases": [
    {
      "name": "Anti-neutrophil cytoplasmic antibody-associated vasculitis",
      "matched_text": "antineutrophil cytoplasmic antibody-associated vasculitis",
      "abbreviation": "AAV",
      "confidence": 1.0,
      "is_rare": true,
      "icd10": null,
      "orpha": "ORPHA:156152"
    },
    {
      "name": "Eosinophilic granulomatosis with polyangiitis",
      "matched_text": "eosinophilic granulomatosis with polyangiitis",
      "abbreviation": "EGPA",
      "confidence": 0.97,
      "is_rare": true,
      "icd10": "M30.1",
      "orpha": "ORPHA:183"
    },
    {
      "name": "Virus-associated trichodysplasia spinulosa",
      "matched_text": "Ts",
      "abbreviation": "TS",
      "confidence": 0.95,
      "is_rare": true,
      "icd10": "L08.8",
      "orpha": "ORPHA:228379"
    },
    {
      "name": "Granulomatosis with polyangiitis",
      "matched_text": "granulomatosis with polyangiitis",
      "abbreviation": "GPA",
      "confidence": 1.0,
      "is_rare": true,
      "icd10": "M31.3",
      "orpha": "ORPHA:900"
    },
    {
      "name": "microscopic polyangiitis",
      "matched_text": "microscopic polyangiitis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": "ICD10CM:M31.7",
      "orpha": "Orphanet:727"
    },
    {
      "name": "Microscopic polyangiitis",
      "matched_text": "MPA",
      "abbreviation": "MPA",
      "confidence": 0.95,
      "is_rare": true,
      "icd10": "M31.7",
      "orpha": "ORPHA:727"
    },
    {
      "name": "rheumatoid arthritis",
      "matched_text": "rheumatoid arthritis",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:284130"
    },
    {
      "name": "depression",
      "matched_text": "depression",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare": false,
      "icd10": "ICD10CM:F32",
      "orpha": null
    },
    {
      "name": "vasculitis",
      "matched_text": "vasculitis",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:52759"
    },
    {
      "name": "arthritis",
      "matched_text": "arthritis",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "diseases",
      "matched_text": "diseases",
      "abbreviation": null,
      "confidence": 0.65,
      "is_rare": false,
      "icd10": null,
      "orpha": "Orphanet:377788"
    },
    {
      "name": "anxiety",
      "matched_text": "anxiety",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare": false,
      "icd10": null,
      "orpha": null
    },
    {
      "name": "GPA",
      "matched_text": "GPA",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare": false,
      "icd10": "ICD10CM:M31.3",
      "orpha": "Orphanet:900"
    }
  ],
  "drugs": [
    {
      "name": "Prednisolone",
      "matched_text": "prednisolone",
      "compound_id": null,
      "confidence": 0.85,
      "is_investigational": true,
      "phase": "ACTIVE_NOT_RECRUITING"
    }
  ],
  "pharma": [
    {
      "name": "AstraZeneca",
      "matched_text": "AstraZeneca",
      "full_name": "AstraZeneca PLC",
      "headquarters": "Cambridge, UK",
      "parent_company": null,
      "confidence": 0.95
    },
    {
      "name": "Novartis",
      "matched_text": "Novartis",
      "full_name": "Novartis AG",
      "headquarters": "Basel, Switzerland",
      "parent_company": null,
      "confidence": 0.95
    },
    {
      "name": "Pfizer",
      "matched_text": "Pfizer",
      "full_name": "Pfizer Inc.",
      "headquarters": "New York, USA",
      "parent_company": null,
      "confidence": 0.95
    }
  ]
}